Full metadata record
DC FieldValueLanguage
dc.contributor.authorPanahi, Yunes-
dc.contributor.authorMojtahedzadeh, Mojtaba-
dc.contributor.authorNajafi, Atabak-
dc.contributor.authorGhaini, Mohammad Reza-
dc.contributor.authorAbdollahi, Mohammad-
dc.contributor.authorSharifzadeh, Mohammad-
dc.contributor.authorAhmadi, Arezoo-
dc.contributor.authorRajaee, Seyyed Mahdi-
dc.contributor.authorSahebkar, Amirhossein-
dc.date.accessioned2017-11-30T12:29:53Z-
dc.date.available2017-11-30T12:29:53Z-
dc.date.issued2017-04-05-
dc.identifier.issn1611-2156-
dc.identifier.urihttp://hdl.handle.net/2003/36225-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-18239-
dc.description.abstractMagnesium (Mg) has been developed as a drug with various clinical uses. Mg is a key cation in physiological processes, and the homeostasis of this cation is crucial for the normal function of body organs. Magnesium sulfate (MgSO4) is a mineral pharmaceutical preparation of magnesium that is used as a neuroprotective agent. One rationale for the frequent use of MgSO4 in critical care is the high incidence of hypomagnesaemia in intensive care unit (ICU) patients. Correction of hypomagnesaemia along with the neuroprotective properties of MgSO4 has generated a wide application for MgSO4 in ICU.en
dc.language.isoen-
dc.relation.ispartofseriesEXCLI Journal;Vol. 16 2017-
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.subjectmagnesium sulfateen
dc.subjectintensive care uniten
dc.subjectneuroprotectionen
dc.subjectICUen
dc.subject.ddc610-
dc.titleThe role of magnesium sulfate in the intensive care uniten
dc.typeText-
dc.type.publicationtypearticle-
dcterms.accessRightsopen access-
eldorado.dnb.zdberstkatid2132560-1-
eldorado.secondarypublicationtrue-
Appears in Collections:Review Articles

Files in This Item:
File Description SizeFormat 
Panahi_05042017_proof.pdfDNB171.56 kBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons